Discovery and multimerization of cross-reactive single-domain antibodies against SARS-like viruses to enhance potency and address emerging SARS-CoV-2 variants
2023 · Scientific Reports · 10 citations
https://doi.org/10.1038/s41598-023-40919-7
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
34
Papers
1.7K
Citations
16
h-index
18
i10-index
Marc Bailly is an academic researcher from Merck & Co., Inc., Rahway, NJ, USA (United States). The author has contributed to research in topics: RNA and protein synthesis mechanisms & RNA modifications and cancer & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 16, co-authored 29 publications.
https://doi.org/10.1038/s41598-023-40919-7
https://doi.org/10.1038/s42003-021-02444-z
Click to start Chat